Expression of chemokines and their receptors in nephrotoxic serum nephritis

Erik Schadde1, Matthias Kretzler1, Bernhard Banas1, Bruno Luckow1, Karel Assmann2 and Detlef Schlöndorff1,

1 Medizinische Poliklinik, Klinikum Innenstadt der Ludwigs-Maximilians-Universität, Munich, Germany and 2 Department of Pathology, University Hospital Nijmegen, Nijmegen, The Netherlands



   Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Background. Chemokines play a major role in leukocyte infiltration in inflammatory kidney diseases. The specificity of the chemokine action is determined by the restricted expression of the corresponding receptors on leukocytes. We therefore simultaneously studied the expression of CC-chemokine and CC-chemokine receptor 1–5 (CCR 1–5) mRNA in an accelerated model of nephrotoxic nephritis in CD-1 mice.

Methods. Kidneys were harvested at day 0, 2 and 7. Induction of nephritis was confirmed by assessment of albuminuria by ELISA and by histological evaluation. RNA was prepared from cortex and isolated glomeruli. RNase protection assays were performed to study the expression of chemokines, RNase protection assays as well as quantitative RT-PCR assays to study the expression of chemokine receptors.

Results. In the cortex of nephritic kidneys mRNA for MCP-1 was increased 5-fold on day 2 and increased 4-fold on day 7 as compared to controls. mRNA for RANTES was increased 5-fold on day 7 and mRNA for IP-10 6-fold on day 7. The increase of mRNA for the chemokine receptors CCR1 and 5 was between 2-fold and 3-fold determined by RNase protection assay and for CCR1, 2 and 5 between 2- and 4-fold as determined by RT-PCR. In isolated glomeruli we found by RT-PCR an increase of CCR1, CCR2 and CCR5 of between 3 and 12-fold.

Conclusion. These results show that chemokines and their specific chemokine receptors are increased in parallel in this model of glomerulonephritis, consistent with the potential role of the chemokine system in leukocyte recruitment to the immune injured kidney.

Keywords: CC-chemokines; chemokine receptors; glomerulonephritis; mouse; nephrotoxic glomerulonephritis



   Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Chemokines are an expanding family of small peptides which, as a major function, recruit specific subsets of leukocytes to sites of tissue injury [1]. Many cell types have the ability to generate chemokines upon stimulation. In the kidney these include mesangial, endothelial, tubular epithelial as well as interstitial cells. Stimuli include proinflammatory cytokines such as IL-1, IFN-{gamma}, TNF-{alpha} as well as immune complexes and tissue injury with generation of reactive oxygen species [2].

The specificity of chemokine action is mediated through selective expression of chemokine receptors by different leukocyte subpopulations. All chemokine receptors are structurally related and belong to the family of seven-transmembrane G-protein coupled receptors. Many chemokine receptors are considered ‘shared receptors’, because in vitro they can bind more than one chemokine [3].

Chemokines have been proposed to attract leukocytes in inflammatory kidney diseases. For example MCP-1 mRNA is increased in timely concordance with macrophage infiltration in rat models of anti-Thy1.1 nephritis [4,5] and of nephrotoxic nephritis [610]. Subsequent studies demonstrated persisting elevated levels of MCP-1, MCP-3, MIP-1{alpha}, MIP1-ß, TCA-3 and RANTES mRNA at 24 h, 3 and 7 days after induction of glomerular injury with anti-GBM antibodies again correlating with persistently elevated numbers of macrophages within the glomeruli [11]. An increase of MCP-1 could also be detected at the protein level in glomerular lysates by ELISA [6]. Pretreatment of rats with a neutralizing anti-MCP-1 antibody before induction of a nephrotoxic nephritis resulted in less morphological damage, a decrease in glomerular macrophage infiltration and a reduction of proteinuria [6,12,13]. The protective effect of anti-MCP-1 and of the RANTES antagonist MetRANTES was confirmed in a murine model of nephrotoxic serum nephritis [14].

Further evidence for a role of chemokines and their receptors in the pathogenesis of experimental nephritis was obtained with the receptor blocker vMIPII. vMIP-II is a chemokine analogue encoded by human herpesvirus 8 with the capacity to bind and block the MCP1-receptor CCR2, the RANTES receptors CCR1, CCR3 and CCR5 and the fractalkine receptor (CX3 CR1). In NTS nephritis in the rat pretreatment with vMIP-II reduced glomerular leukocyte infiltration, morphological damage and proteinuria [15].

A role for chemokines in human kidney diseases is supported by the findings of MCP-1 and RANTES expression in human kidney biopsies correlating with the local infiltration of macrophages [1619]. Furthermore we recently demonstrated the presence of CCR5 positive leukocytes in human biopsies from patients with a variety of renal diseases.

To date, a simultaneous analysis of the expression of chemokines and their receptors in mouse NTS nephritis has not been performed. Such an analysis is the prerequisite to future therapeutic intervention studies targeting the identified chemokines and chemokine receptors. Our results confirm the concerted expression of CC-chemokines and their receptors in murine NTS-nephritis and identify CCR1, CCR2 and CCR5 as potential targets for therapeutic interventions.



   Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Induction of nephrotoxic serum nephritis
Female CD-1 Swiss mice 4–6 weeks old were obtained from Charles River Laboratories, Germany. Accelerated nephrotoxic serum (NTS) nephritis was induced as previously reported [10]. The rabbit antiserum used was a protein A purified IgG fraction. Mice were pre-immunized by intraperitoneal injection of 200 µg of normal rabbit IgG together with TITER MAX (CytRx Corporation, Norcross, US) research adjuvant (1 : 2 in a total volume of 50 µl). After 5 days nephritis was induced by i.v. injection of nephrotoxic IgG (0.4 mg in a total volume of 200 µl PBS). Controls were sham-injected with 0.4 mg of normal rabbit IgG in 200 µl PBS. Experimental and control groups of four mice each were sacrificed at days 0, 2 and 7 after induction of nephritis. Two separate series of experiments were performed.

Assessment of albuminuria
Spot urine specimens were obtained from mice at the time of sacrifice for the determination of the urine protein/creatinine ratio (Up/Ucr) as an index of urinary albumin excretion. Urine creatinine was measured using a Hitachi Autoanalyzer, and urine albumin concentration was measured using an ELISA for mouse albumin (EXOCELL, Philadelphia, PE).

Histological analysis
Kidney sections in the coronary plane were fixed in Bouin's solution. Fixed kidneys were dehydrated and embedded in paraplast (Amstelstad B.V., Amsterdam, The Netherlands). Sections (4 µm) were stained with haematoxylin and eosin and periodic acid-Schiff. Sections were examined for glomerular cellularity and necrosis, crescent formation and interstitial infiltration as described. The percentage of glomerular crescents was assessed by counting 40 glomeruli per section and mouse.

For immunohistology sections were snap frozen in liquid nitrogen and 2–4 µm cryostat sections were obtained. Sections were stained with monospecific FITC-labelled goat anti-mouse Ig (heavy and light chains) and goat anti-mouse C3 serum (both from Cappel Laboratories, West Chester, US), goat anti-rabbit Ig (Nordic, Tilburg, The Netherlands), and rabbit anti-human fibrinogen cross-reacting with mouse fibrinogen (Dako, Copenhagen, Denmark). The sections were examined in a fluorescence microscope equipped with epi-illumination (Leica DBMR, Wetzlar, Germany) and the staining intensity was determined as previously described [10].

The number of glomerular and interstitial macrophages was determined in 5 µm frozen kidney sections with a rat anti-mouse macrophage monoclonal FA/11 antibody [20] (kindly donated by Dr G.L.E. Koch, MRC Laboratory of Molecular Biology, Cambridge, UK) as first antibody, a three step avidin-biotin technique with biotinylated goat anti-rat antibodies [21] as second antibodies and ABC complexes with alkaline phosphatase (Vector Laboratories, Burlingame, US) for histochemical detection. The number of glomerular macrophages was assessed as the mean number per glomerular cross-section (GCS) counted in at least 40 glomeruli per section and mouse. The number of interstitial macrophages was determined as mean per high power field (HPF) from 10 HPS chosen at random per section and mouse (magnification: lens objective 40x, ocular 10x).

Isolation of glomeruli
Glomeruli from four animals per group were isolated by sequential sieving as previously reported [22] with minor modifications. These consisted of addition of collagenase (1 mg/ml, type IV Worthington, Freehold, NJ, US) to the preparation buffer and 2% BSA (Fraction V, Boehringer, Mannheim, Germany) as well as 0.02% TWEEN 20 (Fluka, Buchs, Switzerland) to the washing buffer. The purity of the glomerular fraction was determined by light microscopy and was approximately 90±5%.

mRNA isolation, RNase protection assays and quantitative reverse transcription–PCR
Total RNA was extracted from kidney cortex (half a kidney from two animals per time point) and purified glomeruli fractions (starting material for sieving one and a half kidneys from four animals per time point). Tissues were homogenized in a commercial phenol-guanidine isothiocyanate (GITC) reagent (TRI-Reagent, Molecular Research Center, Cincinatti, OH, US) and total RNA isolated as described by the manufacturer.

Multiprobe template sets for mouse chemokines MCP-1, RANTES, MIP-1{alpha}, MIP-1ß, MIP-2, Eotaxin, IP-10 and TCA-3 and mouse CCR 1–5 for use in RNase protection assays were obtained from Pharmingen (San Diego, US). Protection assays were performed according to manufacturers instructions using 5 µg of total RNA from kidney cortex to detect chemokine RNA on day 2 and 20 µg on day 7 and using 25 µg of RNA from kidney cortex to detect chemokine receptor-RNA. Protected fragments were separated by denaturing polyacrylamide gel electrophoresis. After drying gels were exposed at -80°C on X-ray film using intensifying screens or exposed on phosphor screens for analysis with a Storm 840 Phosphorlmager (Molecular Dynamics, Sunnyvale, USA). Relative expression was calculated as x-fold change compared to controls and corrected for expression of housekeeping genes. Relative expression was determined for two separate series of experiments which resulted in comparable results.

Reverse transcription (RT) and quantitative RT–PCR were performed as described [23]. Contaminating genomic DNA was removed using 5 U of RNase-free DNase (Promega, Ingelheim, Germany) for 15 min at 37°C per RNA sample containing about 2 µg RNA in the presence of 20 U of RNasin (Promega Biotech, Madison, WI, US). DNase was removed by phenol chloroform extraction and ethanol precipitation. The purified RNA was redissolved in 11 µl diethyl-pyrocarbonate-treated water containing 20 U of RNAsin and denatured for 5 min at 65°C in the presence of 0.5 µl (=0.5 µg) oligo (dT)12 oligonucleotides. Aliquots of 100 U of a modified Moloney murine leukomia virus reverse transcriptase (SuperScriptRT, Life Technologies, Eggenstein, Germany) were added and RT performed for 1 h at 42°C. For reverse transcriptase negative controls (RT minus) no enzyme was added.

To detect cDNA for CCR 1–5, sequence-specific 18–22 bp oligonucleotide primers were designed for each receptor based on the published sequences (Table 1Go). A 1 µl sample of the cDNA was then used to perform PCR reactions in 25 µl containing 2.5 µl 10x PCR buffer with 15 mM MgCl2, 4 µl 1.25 mM dNTP, 0.25 µl (=2.5 pmol) forward primer, 0.25 µl (=2.5 pmol) reverse primer, 15.525 µl H2O and 0.125 µl AmpliTaq polymerase (Perkin Elmer, Foster City, CA). Amplifications were performed in a Perkin Elmer Cetus using the following conditions. After denaturation for 3 min at 94°C, samples were cycled 30 times for 1 min at 94°C, 1 min at 56°C, and for 2 min at 72°C; final extension was performed for 7 min at 72°C. To control for variation in tissue mass and RT reaction efficiency, cDNA concentration was adjusted assuming constant adenine-nucleotide-carrier (ANC) concentrations in equal amounts of RNA extracted from tissue (GAPDH and ß-actin-expressions corresponded to ANC expression in multiple experiments in this model—data not shown). For this purpose PCR was performed using oligonucleotide primers selected from published sequences (Table 1Go) on a serial 5-fold dilution series of each cDNA, with assays performed over a 2–3 log range. PCR was then repeated using the standardized cDNA templates to verify equivalent cDNA concentrations at each time point.


View this table:
[in this window]
[in a new window]
 
Table 1. Oligonucleotide primer pairs for CCR1 to 5 and ANC as housekeeper gene used in quantitative RT-PCR. (EMBO-accession numbers for mCCR1: U28404; mCCR2: U47035; mCCR3: U29677; mCCR4: X90862; mCCR5: X94151)

 
To assess changes in cDNA levels of chemokine receptors, PCR was performed using serial 5-fold dilutions of cDNA from each time point. As a positive control, mouse spleen cDNA was serially diluted and used in PCR reactions. The cDNA reaction mix from RT-minus reactions was also included in each PCR run; these samples were consistently negative. All PCR-products were isolated and identity was confirmed by CCR-specific restriction analysis.

To assess product abundance the amplified cDNA was analysed on a non-denaturing 5% polyacrylamide gel, stained with VistraGreen (Amersham, Braunschweig, Germany) and analyzed with ImageQuant Software on a Storm 840 Phosphorlmager. Relative product abundance was evaluated by densitrometric analysis and expressed in relation to controls and corrected for ANC-housekeeper expression. Relative expression was determined for each of two independent series of experiments, which resulted in comparable results.

Statistical analysis
Data were expressed as means±SEM and analysed by Student's t-test for unpaired data. Statistical significance was defined as P<0.05.



   Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Induction of nephritis
Controls injected with PBS as well as those pre-immunized with normal rabbit serum only had urinary albumin concentrations below 10 µg/ml at days 0, day 2 and day 7. Up/Ucr ratios remained stable (below 0.2) in the sham injected mice at days 0, 2 and 7. In contrast Up/Ucr increased 100-fold to 22.2±8.5 at day 2 and 400-fold to 45.7±19.9 at day 7. At sacrifice most of the NTS-injected mice had ascites and two NTS-injected mice died, presumably of renal disease, before day 7.

Morphological analysis
Light microscopy revealed focal segmental deposition of homogenous or finely granular periodic acid-Schiff-positive material in the capillary loops. Capillary dilatation and endothelial cell damage were also apparent in nephritic animals at day 2. An increase of this damage and focal segmental capillary loop necrosis was observed on day 7 (Figure 1Go). No hypercellularity and only few cellular crescents (5%) were noted.



View larger version (177K):
[in this window]
[in a new window]
 
Fig. 1. Glomerular lesions detectable by light microscopy and immunohistochemistry for FA/11 in the accelerated NTS model in CD-1 mice at day 7. PAS staining (A) shows segmental deposition of PAS positive material (*) and beginning of capillary loop necrosis (+) as compared to controls (B). Interstitial macrophages (FA/11 positive) were increased in NTS injected animals on day 7 especially around Bowmans capsule (>). A few macrophages are found within the glomeruli (->) (C). Controls showed rare macrophages in the interstitium (->) of the mouse kidney (D).

 
Immunofluorescence at day 2 showed strong linear staining of the GBM for rabbit and mouse IgG and C3 deposits in a finely granular pattern along the capillary wall and in the mesangial areas. Segmental fibrin deposits were detectable on day 2, but were much stronger on day 7. Staining for the heterologous rabbit and the autologous mouse IgG remained unchanged on day 7. Sections from control kidneys showed no specific staining (data not shown).

Immunohistochemistry for FA/11 positive cells showed occasional macrophages within glomeruli (0.4±0.2/GCS) and some macrophages in the interstitium (3.8±0.3/HPF) of control mouse kidneys. Interstitial macrophages were increased especially around Bowmans capsule in NTS injected animals on day 2 (5.2±0.2/HPF) and day 7 (5.3±0.3/HPF) as compared to controls (3.5±0.2/HPF in controls; P<0.05) (Figure 1Go). No significant increase of macrophages within glomeruli of NTS injected animals was found either on day 2 (0.3±0.1/GCS) or on day 7 (0.5±0.3/GCS vs 0.5±0.2/GCS in controls).

Chemokine expression
Chemokine transcript levels from cortical extracts were determined by RNase protection assay on day 2 and 7. Levels of mRNA for MCP-1 were increased 5-fold on day 2 as compared to controls, whereas RANTES and IP-10 were detectable, but not increased as compared to controls (Figure 2Go). On day 7 an increase of MCP-1 (4-fold), RANTES (5-fold), and IP-10 (6-fold) occurred as compared to controls (Figure 2Go). MIP-1{alpha} and MIP-2 were not detectable in mouse kidney extracts. MIP-1ß and TCA-3 were detectable on day 2 in experimental animals but expression levels were low. We also noted a slight basal expression of lymphotactin and eotaxin in both NTS and control groups (Figure 2Go). These results were confirmed in two series of independent experiments. The MCP-1 signal shows several bands. This does not reflect different splice variants but is caused by a principle problem of the multi-probe protection assay system. As eleven different probes are used in parallel in one reaction, the RNase digestion conditions are not optimal for each probe. This can result in the appearance of several bands for a probe. In fact in control experiments the MCP-1 signal could be reduced to one single band by reducing the concentration of RNase. However, under these conditions hybrids with other probes are not digested to completion. Clearly in the case of MCP-1 the multiple bands can be assigned to MCP-1.



View larger version (73K):
[in this window]
[in a new window]
 
Fig. 2. RNase protection assays for the detection of CC-chemokine mRNA at day 0, 2 and 7 after nephritis induction. RNA was analysed by multiprobe RNases protection assays for the presence of chemokine transcripts. Cortex RNA (5 µg) was analysed from the controls at day of injection (C0) and day 2 (C2) and from experimental animals at day 2 (2E). Aliquots of 20 µg of cortex RNA were used for the experimental and control animals at day 7 (7C and 7E) and loaded on a different gel. The undigested probes are shown in the left lane and the protected fragments are indicated on the right. L32 and GAPDH gene products were used as controls for equal loading of the gel. By densitrometry the amount of housekeeper RNA differed by less than 15%. The additional band below TCA-3 in the left lane was observed occasionally and represents most likely an incomplete transcript. The identity of all probes was confirmed by sequence analysis (data not shown). The figure is representative for two separate series of experiments, each analysed twice with comparable results.

 

Chemokine receptor expression
Chemokine receptor transcripts were determined by RT-PCR using total RNA both from renal cortex and isolated glomeruli. In renal cortex cDNA for CCR1, CCR2 and CCR5 could be detected. Nephritic kidneys showed higher cDNA levels at day 2 and day 7, respectively, for CCR1 (2-fold/2-fold), CCR2 (4-fold/4-fold), and CCR5 (2-fold/5-fold) (Figure 3Go). We could not detect cDNA for CCR4 using standard PCR-conditions. Results were confirmed in two series of independent experiments which were analysed twice. Analysing isolated glomeruli by RT-PCR, cDNA for CCR1, 2 and 5 could be detected. According to densitrometric analysis glomeruli from nephritic kidneys showed elevated cDNA levels on day 2 and day 7, respectively, for CCR1 (6-fold/4-fold), CCR2 (5-fold/5-fold), and CCR5 (8-fold/12-fold) (Figure 3Go).



View larger version (43K):
[in this window]
[in a new window]
 
Fig. 3. CC-chemokine receptor CCR 1–5 expression in cortex (left) and isolated glomeruli (right) of kidneys from nephritic mice versus controls as determined by RT-PCR. RNA prepared from kidney cortex and isolated glomeruli as analysed by RT-PCR. CCR1, 2 and 5 were detected in cortex and additionally CCR3 was detected in isolated glomeruli. To assess changes in cDNA levels of CCR 1–5, PCR was performed using serial dilutions of cDNA from each time point. The two dilution steps that were quantified are shown here. Transcript levels for CCR1 were higher than all other CCRs in cortex as well as in glomeruli. Lowest expression levels were found for CCR2 in cortex and CCR5 in isolated glomeruli. Transcripts for CCR1, 2 and 5 were increased in nephritic animals as compared to controls as assessed by densitrometry. The increase was considerably higher in isolated glomeruli.

 
To confirm the results obtained with RT-PCR we performed RNase protection assays with RNA from renal cortex using probes specific for CCR1, CCR2, CCR3, CCR4 and CCR5. Because of the small amount of RNA available from isolated glomeruli only cortex could be analysed by RNase protection assays. Using 30 µg of total RNA only CCR1, CCR2, and CCR5 could be detected in controls. According to densitrometric analysis nephritic kidneys showed elevated levels for CCR1 (2-fold) and CCR5 (3-fold) on both day 2 and day 7 whereas levels for CCR2 were unchanged (Figure 4Go). These result were also confirmed in two series of independent experiments.



View larger version (73K):
[in this window]
[in a new window]
 
Fig. 4. CC-chemokine receptor CCR 1–5 expression in renal cortex of the kidneys of nephritic mice versus controls as determined by RNase protection assay. RNA from kidney cortex was analysed by multiprobe RNase protection assay for the presence of CCR transcripts. Transcripts for CCR1, 2 and 5 were detected. Transcripts for CCR1 and 5 were increased in nephritic animals in RNase protection assays as assessed by densitrometry. The figures are representative for two separate series of experiments analysed twice with comparable results.

 



   Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
We examined the chemokine and chemokine-receptor (CCR) profile at day 2 and 7 of the autologous phase of accelerated nephrotoxic nephritis. Our findings are: (i) an increase in the expression of the chemokines MCP-1 on day 2 in nephritic kidneys; an increase of MCP-1, RANTES and IP-10 on day 7 post-nephritis induction, and (ii) an increase in CCR1, 2 and 5 expression in renal cortex and even more in isolated glomeruli of nephritic animals.

Chemokines are supposed to play a role in attracting leukocytes to sites of injury in NTS nephritis [2]. Therefore it was of interest to find elevated CC-chemokine levels in nephritic kidneys, as noted in previous studies: MCP-1 is increased at 24 h [24] and up to 48 h [25] in rat models of nephrotoxic nephritis. MCP-1 protein was detected immunohistochemically in glomeruli, vascular endothelial cells, and tubular epithelial cells on day 3 and 6 of rat NTS nephritis but not in controls [26]. Studies of murine NTS nephritis found that MCP-1 and RANTES were increased at day 3 [10] and remained elevated until day 14 [14]. In concordance with the latter study we could also detect an increase of RANTES levels. RANTES expression has been shown to be increased in the rat model [11] and generally seems to start late after the induction of disease [11,14]. Again in concordance with Lloyd et al., we could not detect an increase of MIP-1{alpha}, MIP-1ß or TCA-3 in nephritic kidneys. This is in contrast to results obtained in rat NTS [11,24,27]. We also observed an increase of IP-10 in mouse NTS nephritis as previously reported in rat nephritis [28]. These differences of the chemokine expression profile between rat and mouse may indicate species specificities.

The effect of a chemokine depends on the presence of chemokine receptors on target cells. Whereas chemokines can be produced by multiple cells in inflammatory states, CCR expression is mostly restricted to leukocytes. The low basal level of expression of CCR1, CCR2 and CCR5 which was observed in control kidneys is most likely due to the presence of leukocytes in the renal tissue. It should be noted that kidneys were not perfused free of blood prior to processing so that blood leukocytes would be present in the tissue. In the accelerated model of NTS nephritis we found predominantly an interstitial and periglomerular leukocyte infiltration. It is reasonable to assume that the increase of CCR transcripts in nephritic cortex arises from the interstitial macrophage and T-cell infiltrate, an assumption that will need future immunohistological evaluation. Isolated glomeruli were only studied by RT-PCR because of the small, limited amount of material isolated. Interestingly, the upregulation of CCR transcripts in nephritic glomeruli was about 3-fold higher than the upregulation observed in renal cortex. As the number of glomerular mononuclear cells is not markedly increased in this mouse model [29], the marked increase in glomerular mRNA levels for CCR either results from their upregulation on the mononuclear cells present, or perhaps from adherent periglomerular leukocytes in the isolated glomerular preparations.

CCR1 (receptor for MIP-1{alpha}, MCP-3 and RANTES) is expressed on monocytes and activated T-cells. Interestingly we could recently show that human mesangial cells express this receptor after stimulation with IFN-{gamma} [30]. Potentially the increase of CCR1 receptor expression in our model could occur on mesangial cells. As CCR1 knockout mice have recently been reported to have worse NTS disease than their wild-type controls [31], the CCR1 receptor might even act in a counter-regulatory fashion.

CCR2 is so far the only known receptor for MCP-1. MCP-1 is known to play a functional role in NTS-nephritis as blocking of MCP-1 improved mononuclear cell infiltration, glomerular and interstitial damage and proteinuria [6,12,13,26,32]. Our results show increased CCR2 levels by RT-PCR but not in RNase protection assay in nephritic renal cortex. This may be due to the higher sensitivity of RT-PCR. In any case there is a definite upregulation of CCR-2 transcripts in isolated glomeruli by RT–PCR.

CCR5 (receptor for RANTES, MIP-1ß and MIP-1{alpha}) can be expressed on monocytes, activated T-cells and NK cells. By in situ hybridization Eitner et al. reported CCR5 expression only on infiltrating cells in human allograft rejection but could not detect CCR5 on intrinsic renal cells [33]. By immunohistochemistry we also detected CCR5 only on CD3-positive T cells in human transplant biopsies as well as in a variety of human glomerular and tubulointerstitial diseases [34].

Unfortunately at present the lack of appropriate antibodies for murine chemokine receptors does not allow assignment of the various CCRs to specific cell types in the mouse kidneys. It should be noted, however, that there is a reasonable correlation between the upregulation of mRNA for the chemokine receptors and their respective ligands in the murine NTS nephritis studied (Figure 5Go). The future assignment of CC-chemokine receptors to specific cell types will be a first step towards identification of potential therapeutic targets for chemokine receptor blockade. Because of binding of CC-chemokines to multiple receptors and the presence of multiple chemokine receptors an ideal receptor antagonist should be able to block the binding of several chemokines to multiple receptors in parallel. Such broad-spectrum antagonists may prove to be of considerable therapeutic value in the future.



View larger version (10K):
[in this window]
[in a new window]
 
Fig. 5. Correspondence between upregulation of CC-chemokines and CCR 1–5 transcripts as determined by RT-PCR in cortex and isolated glomeruli in nephritic mice on day 7. The chemokine ligands and their respective receptors are connected by arrows.

 



   Acknowledgments
 
This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (M.K., B.L.). Part of this work was performed in the context of a doctoral thesis of E.S. at the Faculty of Medicine, Ludwigs-Maximilians-Universität (in preparation).



   Notes
 
Correspondence and offprint requests to: Detlef Schlöndorff, MD, Medizinische Poliklinik, Klinikum Innenstadt der Ludwigs-Maximilians-Universität, Pettenkoferstr. 8a, D-80336 Munich, Germany. Back



   References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol1997; 15: 675–705[ISI][Medline]
  2. Schlondorff D, Nelson PJ, Luckow B, Banas B. Chemokines and renal disease. Kidney Int1997; 51: 610–621[ISI][Medline]
  3. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nature Med1996; 2: 1174–1178[ISI][Medline]
  4. Stahl RA, Thaiss F, Disser M, Helmchen U et al. Increased expression of monocyte chemoattractant protein-1 in anti- thymocyte antibody-induced glomerulonephritis. Kidney Int1993; 44: 1036–1047[ISI][Medline]
  5. Wenzel U, Schneider A, Valente AJ, Abboud HE et al. Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int1997; 51: 770–776[ISI][Medline]
  6. Tang WW, Qi M, Warren JS. Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int1996; 50: 665–671[ISI][Medline]
  7. Tam FW, Karkar AM, Smith J, Yoshimura T et al. Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis. Kidney Int1996; 49: 715–721[ISI][Medline]
  8. Sekiguchi M, Natori Y, Iyonaga K, Takeya M. Expression of monocyte chemoattractant protein-1 in experimental crescentic glomerulonephritis in rats. J Lab Clin Med1997; 129: 239–244[ISI][Medline]
  9. Wu X, Dolecki GJ, Sherry B, Zagorski J et al. Chemokines are expressed in a myeloid cell-dependent fashion and mediate distinct functions in immune complex glomerulonephritis in rat. J Immunol1997; 158: 3917–3924[Abstract]
  10. Neugarten J, Feith GW, Assmann KJ, Shan Z et al. Role of macrophages and colony-stimulating factor-1 in murine antiglomerular basement membrane glomerulonephritis. J Am Soc Nephrol1995; 5: 1903–1909[Abstract]
  11. Natori Y, Sekiguchi M, Ou Z. Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN). Clin Exp Immunol1997; 109: 143–148[ISI][Medline]
  12. Fujinaka H, Yamamoto T, Takeya M, Feng L et al. Suppression of anti-glomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats. J Am Soc Nephrol1997; 8: 1174–1178[Abstract]
  13. Harada A, Mukaida N, Matsushima K. Use of blocking antibodies as probes for in vivo functions of chemokines. Methods1996; 10: 166–174[Medline]
  14. Lloyd CM, Minto AW, Dorf ME, Proudfoot A et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med1997; 185: 1371–1380[Abstract/Free Full Text]
  15. Chen S, Bacon KB, Li L, Garcia GE et al. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med1998; 188: 193–198[Abstract/Free Full Text]
  16. Prodjosudjadi W, Gerritsma JS, van Es LA et al. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol1995; 44: 148–155[ISI][Medline]
  17. Wada T, Yokoyama H, Su SB et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int1996; 49: 761–764[ISI][Medline]
  18. Pattison J, Nelson PJ, Huie P et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet1994; 343: 209–211[ISI][Medline]
  19. Robertson H, Wheeler J, Morley AR et al. Beta-chemokine expression and distribution in paraffin-embedded transplant renal biopsy sections: analysis by scanning laser confocal microscopy. Histochem Cell Biol1998; 110: 207–213[ISI][Medline]
  20. Smith MJ, Koch GL. Differential expression of murine macrophage surface glycoprotein antigens in intracellular membranes. J Cell Sci1987; 87: 113–119[Abstract]
  21. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem1981; 29: 577–580[Abstract]
  22. Schlondorff D. Preparation and study of isolated glomeruli. Methods Enzymol1990; 191: 130–140[Medline]
  23. Kretzler M, Fan G, Rose D et al. Novel mouse embryonic renal marker gene products differentially expressed during kidney development. Am J Physiol1996; 271: F770–777[Abstract/Free Full Text]
  24. Tang WW, Yin S, Wittwer AJ, Qi M. Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. Am J Physiol1995; 269: F323–F330[Abstract/Free Full Text]
  25. Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest1994; 71: 536–542[ISI][Medline]
  26. Wada T, Yokoyama H, Furuichi K et al. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). Faseb J1996; 10: 1418–1425[Abstract/Free Full Text]
  27. Luo Y, Laning J, Devi S et al. Biologic activities of the murine beta-chemokine TCA3. J Immunol1994; 153: 4616–4624[Abstract/Free Full Text]
  28. Brown Z, Robson RL, Westwick J. Regulation and expression of chemokines: potential role in glomerulonephritis. J Leukoc Biol1996; 59: 75–80[Abstract]
  29. Feith GW, Assmann KJM, Bogmann MJJT, van Gompel APM, et al. Severe albuminuria and morphological damage in a reproducible model of accelerated autologous anti-GBM-nephritis in the mouse. submitted;
  30. Banas B, Luckow B, Möller M, Holthöfer H et al. Chemokine and chemokine receptor expression in a novel human mesangial cell line. JASN1998; 10: 2314–2322[Abstract/Free Full Text]
  31. Topham P, Hines D, Csizmadia V et al. Regulatory role of CCR1 pathway in glomerulonephritis. CCR1 knockout mice show enhanced glomerular injury. JASN1998; 9: M651 [abstract]
  32. Lloyd CM, Dorf ME, Proudfoot A et al. Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol1997; 62: 676–680[Abstract]
  33. Eitner F, Cui Y, Hudkins KL et al. Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int1998; 54: 1945–1954[ISI][Medline]
  34. Segerer S, Mack M, Regele H et al. Expression of the chemokine receptor CCR5 in human kidney diseases. Kidney Int1999; 56: 52–64[ISI][Medline]
Received for publication: 11. 6.99
Revision received 13. 1.00.